Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda

INTRODUCTION: COSTOP was a randomised controlled trial designed to assess the risks and benefits to HIV-infected participants stabilised on anti-retroviral treatment of stopping cotrimoxazole (CTX). In order to assess the extent to which patients may have had access to and used CTX other than that s...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunn, Andrew, Anywaine, Zacchaeus, Seeley, Janet, Munderi, Paula, Levin, Jonathan, Kasirye, Ronnie, Kamali, Anatoli, Abaasa, Andrew, Grosskurth, Heiner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918030/
https://www.ncbi.nlm.nih.gov/pubmed/27536738
http://dx.doi.org/10.1016/j.conctc.2016.05.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918030/
https://www.ncbi.nlm.nih.gov/pubmed/27536738
http://dx.doi.org/10.1016/j.conctc.2016.05.008

Ejemplares similares